SAN FRANCISCO, Oct. 29 – Xanthon will partner with Duke University and University of North Carolina at Chapel Hill scientists in a two-year oligonucleotide array project that received funding from the North Carolina Biotechnology Center, the company announced Monday.

The project is called “Fabrication and Interrogation of Ultradense Oligonucleotide Arrays.” Xanthon will commercialize resulting technology, the company said.

Grant amount and details of the agreement between Xanthon and the universities were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more